Skip to main content
Apt Medical Inc. logo

Apt Medical Inc. — Investor Relations & Filings

Ticker · 688617 ISIN · CNE100004C45 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 662 across all filing types
Latest filing 2022-12-14 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688617

About Apt Medical Inc.

https://www.aptmed.com/

Apt Medical Inc. is a specialized developer and manufacturer of advanced medical devices for minimally invasive vascular interventions. The company focuses on the fields of electrophysiology, interventional cardiology, and peripheral vascular procedures. Its product portfolio includes diagnostic and ablation catheters, steerable sheaths, guide wires, microcatheters, and balloon catheters designed for complex cardiovascular treatments. Apt Medical emphasizes research and development to provide high-precision tools for clinicians, aiming to improve procedural outcomes in the treatment of cardiac arrhythmias and vascular diseases. The company serves a global market, providing integrated solutions for interventional procedures through a commitment to technological innovation and quality manufacturing standards.

Recent filings

Filing Released Lang Actions
独立董事关于第二届董事会第二次会议相关议案的独立意见
Board/Management Information Classification · 95% confidence The document is titled as an independent opinion from independent directors regarding proposals discussed at the second meeting of the second board of directors of Shenzhen Huitai Medical Devices Co., Ltd. It contains independent directors' opinions on specific board meeting agenda items such as related party transactions, use of idle raised funds for cash management, and expected related party transactions for 2023. The document is signed by independent directors and dated December 14, 2022. It does not contain financial statements or detailed financial data but rather opinions on board meeting proposals. This fits the category of Board/Management Information (MANG), which includes announcements related to board meetings and management decisions. The document length is short (1368 characters), and it is not a report publication announcement or certification. Therefore, the best classification is MANG with high confidence.
2022-12-14 Chinese
关于使用部分暂时闲置募集资金进行现金管理的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Shenzhen Huitai Medical Devices Co., Ltd. regarding the use of temporarily idle raised funds for cash management. It details the board meeting approval, investment scope, amount, duration, risk analysis, and compliance with regulatory requirements. The document does not contain financial statements or detailed financial results but is a regulatory disclosure about the company's use of raised funds. It is not an annual report, interim report, earnings release, or audit report. It is a formal announcement related to capital management and financing activities, specifically about the use of idle raised funds for cash management. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 3828 characters, which is sufficient for a detailed announcement but not a full financial report.
2022-12-14 Chinese
中信证券股份有限公司关于深圳惠泰医疗器械股份有限公司放弃优先购买权、向参股公司增资构成与关联方共同投资暨关联交易的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from CITIC Securities Co., Ltd. regarding the waiver of preemptive rights and capital increase in an associate company, Shenzhen Huitai Medical Device Co., Ltd. It discusses the related party transactions, the background, necessity, pricing, and impact of these transactions, as well as the approval process including board and supervisory committee meetings and independent directors' opinions. The document includes extensive financial data, shareholder structure changes, and legal compliance statements. It is not a simple announcement but a comprehensive verification and opinion report on a specific related party transaction. This fits the category of an Audit Report / Information (AR), as it involves regulatory compliance, internal review, and detailed transaction analysis related to accounting and corporate governance, but it is not a full annual report or earnings release. The length and detail confirm it is not a brief announcement or a proxy statement. Therefore, the appropriate classification is AR with high confidence. 9M 2022
2022-12-14 Chinese
关于公司放弃优先购买权、向参股公司增资构成与关联方共同投资暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding a company's decision to waive preemptive rights and increase capital in an associate company, involving related party transactions. It includes extensive information about the transaction, parties involved, shareholding changes, financial data of related entities, legal and procedural compliance, and opinions from independent directors and the sponsor institution. The document is not a financial report like an annual or interim report, nor is it a simple announcement of a report publication. It is a regulatory announcement about a capital increase and related party transactions, which fits the category of Capital/Financing Update (CAP).
2022-12-14 Chinese
关于2023年度日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's expected related party transactions for the fiscal year 2023. It includes details about the nature, amounts, and approval process of these transactions, as well as opinions from independent directors and the supervisory board. The document is a formal disclosure of anticipated related party dealings and their compliance with regulations, rather than a full financial report or detailed management analysis. It does not contain comprehensive financial statements or earnings data, nor is it a report of voting results or a proxy solicitation. The content fits best under a regulatory announcement category that covers miscellaneous compliance disclosures and announcements that do not fit other specific categories. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (8253 characters) and detailed content support this classification with high confidence.
2022-12-14 Chinese
关于召开2022年第三次临时股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2022 third extraordinary general meeting of shareholders for Shenzhen Huitai Medical Devices Co., Ltd. It details the meeting date, voting methods, agenda items, registration procedures, and includes an authorization proxy form for voting. There is no financial data, earnings, or report content. The document is an announcement related to a shareholder meeting, specifically a notice of the meeting and proxy voting instructions. This fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings. The document length is under 5,000 characters and it is not a report publication announcement or certification. Therefore, the classification is AGM-R with high confidence.
2022-12-14 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.